Nanotechnology-based drug delivery of ropinirole for Parkinson's disease

• Auteurs principaux: Emilia Barcia (Auteur), Liudmila Boeva (Auteur), Luis García-García (Auteur), Karla Slowing (Auteur), Ana Fernández-Carballido (Auteur), Yaquelyn Casanova (Auteur), Sofía Negro (Auteur)
• Format: Livre
• Publié: Taylor & Francis Group, 2017-01-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

A new drug delivery system is developed for ropinirole (RP) for the treatment of Parkinson's disease (PD) consisting of biodegradable poly (D,L-lactide-co-glycolide) (PLGA) nanoparticles (NPs). The formulation selected was prepared with 8 mg RP and 50 mg PLGA 502. This formulation exhibited mea...